Drug profile · INN
dolutegravir lamivudine tenofovir alafenamide
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dolutegravir lamivudine tenofovir alafenamide (DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is dolutegravir lamivudine tenofovir alafenamide?
dolutegravir lamivudine tenofovir alafenamide (DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for dolutegravir lamivudine tenofovir alafenamide?
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE is a marketed brand name for dolutegravir lamivudine tenofovir alafenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dolutegravir lamivudine tenofovir alafenamide?
dolutegravir lamivudine tenofovir alafenamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.